Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Point-of-Care, Biosensors and Rapid Dx Europe 2024

Point-of-Care, Biosensors and Rapid Dx Europe 2024 Agenda

Co-Located Conference Agendas

Circulating Biomarkers and Extracellular Vesicles Europe 2024 | Lab-on-a-Chip and Microfluidics Europe 2024 | Organoids and Spheroids Europe 2024 | Point-of-Care, Biosensors and Rapid Dx Europe 2024 | 

Print Agenda

Monday, 24 June 2024


Please View Conference Programming Details in the:

LOACEU2024 Track Morning Plenary Session -- Coolsingel Room

ORGANOIDS Track Afternoon Session -- Conrad Room

EV Track Afternoon Session -- Coolsingel Room

Tuesday, 25 June 2024


Please View Conference Morning Programming Details in the:

LOACEU2024 -- Coolsingel Room

Organoids & Spheroids -- Conrad Room


Networking Buffet Lunch -- Network with Exhibitors and View Posters

Session Title: Emerging Technologies and Themes in the Point-of-Care and Rapid Diagnostics Field

Session Venue: Conrad Room

Session Chairperson: Professor Dr. Nicole Pamme


Erik VollebregtKeynote Presentation

Title to be Confirmed.
Erik Vollebregt, Partner, Axon Lawyers, Netherlands


Nicole PammeKeynote Presentation

Microfluidic Devices for On-Site Chemical Sensing
Nicole Pamme, Professor in Analytical Chemistry, Stockholm University, Sweden

Our research centers on the study of microfluidic lab-on-a-chip devices applied to environmental analysis, biomedical research and the synthesis of smart materials. Microfluidic devices offer the possibility for in-the-field and point-of-care analysis provided the devices are portable, require only minimal external instrumentation and little power and are robust. In our group, we are investigating a developing paper microfluidic devices for on-site measurement of water quality markers that are being tested by members of the general public who upload data via a custom-built app for data collection with high spatial and temporal resolution. Furthermore, we develop on-site workflows that enable farmers in resource-limited settings to monitor soil chemistry on their own land.


Ines AntunesKeynote Presentation

ESA SciSpacE Human Research Programme
Ines Antunes, Science Coordinator, European Space Agency (ESA), Netherlands

Presentation of the challenges faced by astronauts during long-duration space missions and how the European Space Agency (ESA) is supporting their health and performance through research on the impact of space conditions on the human body and the development of countermeasures and point of care technologies to investigate changes and mitigate those consequences. The presentation will focus on ESA's SciSpacE team, which conducts research in ground analogues, suborbital platforms, and on the International Space Station (ISS), and how the research conducted in space can benefit terrestrial medicine. The process of ideation, call for proposals, review, selection, and implementation of research projects will also be outlined. The presentation aims to provide insights into how ESA is working to keep astronauts healthy and productive during long-term space missions and how these efforts can also benefit medical science on Earth.


Mid-Afternoon Coffee Break and Networking


Best Poster Awards Sponsored by Lab-on-a-Chip Journal, Royal Society of Chemistry (RSC) -- In the Coolsingel Room


Tackling the Global Health Threat Posed by Fungal and Oomycete Diseases Using Lab-on-a-Chip Devices
Ayelen Tayagui, Research Fellow, University of Canterbury, New Zealand

Lab-on-a-Chip devices can enhance the study of disease-causing microorganisms and tackle their effects on global health.  We describe the design, manufacture and use of devices use to study the forces these organisms use to to infect their hosts.


Towards Continuous Cytokine Monitoring in Organ-based Platforms
Maud Linssen, Researcher, Eindhoven University of Technology (TU/E), Netherlands

Investigations on organ-based platforms such as organoids, organ-on-a-chip, and transplantation organs, require monitoring strategies in order to optimally control the biological systems. However, there is a lack of tools to continuously measure specific low-concentration biomarkers with minimal perturbation. Biosensing by Particle Motion (BPM) is a sensing method with single-molecule resolution that has been specifically designed to enable the continuous monitoring of biomolecules at low concentrations, such as nucleic acids, metabolites, proteins and hormones. The method relies on tracking the motion of individual biofunctionalized particles (1 µm in diameter) that interact with a biofunctionalized substrate. The particles switch between bound and unbound states due to reversible single-molecule interactions, dependent on the presence of analyte molecules. Recently, sampling by microdialysis has been investigated [3]. In this paper we present the development of a BPM sensor to measure cytokines, exemplified with the detection of Interleukin-6 and TNF-a. We will present a study of molecular binders and coupling strategies, focusing on sensitivity and reversibility of the sensor. Furthermore, measurements with microdialysis will be shown. Finally, we will discuss the prospects of using BPM and microdialysis for the continuous monitoring of low-concentration biomarkers in organ-based platforms.


Luxembourg Institute of Science and TechnologyElectroMed – A Programmable Peptide/Protein Screening Platform for Immunology
Cesar Pascual García, Lead Research Scientist, Luxembourg Institute of Science and Technology

Immunology has advanced significantly in recent years thanks to a better knowledge of molecular protein recognition, which has allowed for the creation of innovative treatment options such as genetic vaccines and cell therapies. However, there is a need to accelerate the process of epitope recognition by proteins in order to generate personalized therapies. ElectroMed has been a project with six European partners in which we created a concept for a programmable peptide screening platform based on an array of Immuno-FET sensors with programmable peptide receptors synthesized in-situ using electrochemically generated acid.

A proof-of-concept has been demonstrated by controlling the deprotection of acid labile groups, which enables a high purity synthesis of crude peptides. We remove diffusion-limited processes in chemistry by automating the peptide synthesis and using microfluidic flow in-situ synthesis in planar sensors, allowing us to expedite time to results. FET sensors have the potential to provide online quality control of peptide synthesis by detecting the fingerprints of acid labile group protection and deprotection, as well as superior information quality because label-free sensors can provide kinetic information.

In conclusion, our approach has the potential to speed research into peptide protein screening of linear peptide sequences. In this talk we will review our results and provide the context for the applications in immunology.


Speaker to be Confirmed


Close of Day 2 Conference Programming

Add to Calendar ▼2024-06-24 00:00:002024-06-25 00:00:00Europe/LondonPoint-of-Care, Biosensors and Rapid Dx Europe 2024Point-of-Care, Biosensors and Rapid Dx Europe 2024 in Rotterdam, The NetherlandsRotterdam, The